Correction to: Scientific Reports https://doi.org/10.1038/s41598-023-46611-0, published online 13 November 2023

The original version of this Article contained an error in the Results section, under the subheading ‘Treatment with rhIGF-1/rhIGFBP-3 and rate of survival’,

“The survival at 48 h following IVH was 63.6% (n = 7 out of 11) in the vehicle administered group and 87.5% (n = 7 out of 8) in the rhIGF-1/rhIGFBP-3 administered group (Fig. 2 and Table 3).”

now reads:

“The survival at 48 h following IVH was 72.7% (n = 8 out of 11) in the vehicle administered group and 87.5% (n = 7 out of 8) in the rhIGF-1/rhIGFBP-3 administered group (Fig. 2 and Table 3).”

Additionally, as the result of this error, Figure 2 was incorrect. The original Figure 2 and accompanying legend appear below.

Figure 2
figure 2

Survival in experiment B. Preterm rabbit pups were s.c. administered with rhIGF-1/rhIGFBP-3 (8 mg/kg/dose, n = 38) or vehicle (n = 39) at approximately 3 h of age, and thereafter every 12 h for a total of 5 administrations. A single i.p. bolus of 50% glycerol solution was administered at 6 h of age to induce IVH. Animals were followed up until 54 h of postnatal age, corresponding to 48 h post-glycerol administration, at which point the extent of bleeding was assessed by HFU (bleedings were scored as IVH or No IVH), and survival was evaluated. For details of the experiment and results see “Methods” and “Results” sections. Results are presented in a bar graph. Differences between groups were analyzed using Fischer’s exact test with P-value and the difference between proportions as attributable risk in percent (%).

Full size image

The original Article has been corrected.